 |
| Investors |
|
| Investor Relations |
55 Corporate Drive
Bridgewater, NJ 08807
Tel: (888) 516-3002
Fax: (908) 981-7870
Via email |
|
|
|
|
|
Sanofi-aventis is one of the world’s largest pharmaceutical companies, ranking number one in Europe. In the U.S., which is the fastest growing market region for the company, sanofi-aventis currently ranks among the top five pharmaceutical companies. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines.
|
|
Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). The corporate headquarters are based in Paris, France. The headquarters of our U.S. organization are based in Bridgewater, New Jersey. For more information on sanofi-aventis in the U.S., please click here.
The sanofi-aventis Investor Relations team is committed to providing the investment community with timely, transparent information on the Group’s business, organization and performance.
If you are an institutional investor or U.S. individual shareholder, you can contact us in the United States: - Phone: +1 888 516 3002 (toll free in the U.S.)
- E-mail
|
| Last update: October 31, 2006 |
|
|
|
